Solvent naphtha (petroleum) heavy aromatic.
定义
Solvent naphtha (petroleum) heavy aromatic. A complex combination of hydrocarbons obtained from distillation of aromatic streams. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C12-15
化妆品中的作用
溶解其他成分的基质SOLVENT
安全与法规参考
未列入韩国有毒物质 GHS 分类 · 现有化学物质
Other restriction: ban substances that deplete the ozone layer
来源: 欧盟 CosIng 成分清单
详细资料——标示名称、识别编号、物性、试验记录、文献
别名和识别信息
C12-15 ALKANE/CYCLOALKANE/AROMATIC HYDROCARBONSINCIC12-15알케인/사이클로알케인/아로마틱하이드로카본韩国标示名称（食药处标准名）Solvent naphtha (petroleum), heavy arom.同义名
- CAS No.化学物质登记号
- 64742-94-5
- EC No.欧盟化学品目录编号
- 265-198-5
- DTXSID美国EPA化学品编号
- DTXSID9028251
产品实际使用的用途
这是向美国 EPA 申报含该成分的 36 款产品的用途。其中包括化妆品以外的产品，排在前几行的即为该成分的主要用途。
- Solvent16
- Processing aids not otherwise specified4
- Lubricating agent4
- Binder2
- Surfactant (surface active agent)2
- Defoamer2
- Fuel agents2
- Viscosity modifier1
其余用途 3 项
- Dispersing agent1
- Fuel1
- Demulsifier1
来源: 美国EPA CompTox
刺激与致敏试验记录
记录有皮肤试验 15 项、眼部试验 8 项。
归类为刺激性高12 项归类为中等1 项归类为低18 项
各项试验结论不一（最多的结论占 39%），因此不能断定该成分有刺激性。 这是对原料本身的试验记录，与成品中所含浓度下的刺激性不同。
查看全部 23 项试验
- Severe Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to - Severe Irritation
skin irritation: in vivo · Screening · other guideline: EPA Guidelines in FR Vol. 44, No. 145, pgs 44054-44093 according to - Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · equivalent or similar to EPA OTS 798.4100 (Skin Sensitisation) - Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · according to other guideline: EPA guidelines in FR Vol. 44, No. 145, pgs. 44054-44093 - Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · according to other guideline: EPA guidelines in FR Vol. 44, No. 145, pgs 44054-44093 - Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · according to EPA OTS 798.4100 (Skin Sensitisation) equivalent or similar to OECD Guideline 406 (Skin Sensitisation) - Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · according to EPA OTS 798.4100 (Skin Sensitisation) - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to - Severe Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to - Severe Irritation
skin irritation: in vivo · Screening · EPA OTS 798.4470 (Acute Dermal Irritation) according to - Category 2
Skin Irritation · Screening - Severe Irritation
skin irritation: in vivo · Screening · other guideline: EPA Guidelines in FR Vol. 44, No. 145, pgs. 44054-44093 according to - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · EPA OTS 798.4470 (Acute Dermal Irritation) according to OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to - Classification not possible
Skin Sensitization · Screening - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · EPA OTS 798.4500 (Acute Eye Irritation) equivalent or similar to - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion) according to - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) equivalent or similar to - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion) according to OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · EPA OTS 798.4500 (Acute Eye Irritation) according to - Category 2
Eye Irritation · Screening - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · other guideline: EPA Guidelines in FR Vol. 44, No. 145, pgs. 44054-44093 according to
来源: 美国EPA CompTox